logo of Ironwood Pharmaceuticals
logo of Ironwood Pharmaceuticals

Ironwood Pharmaceuticals Stock

Detail Data
Volume (24h): 1,977,294 shares
P/E Ratio: 93.23
Forward P/E: 2.45
EPS: 0.01 USD
Forward EPS: 0.38 USD
Number of Shares: 161,820,000 shares
Market Capitalization: 150,864,784.00 USD

Dividend

Dividend Value
Dividend Amount According to our data, the company Ironwood Pharmaceuticals does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: -
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: -
Last Dividend Date: -

Analyst Forecast

Most analysts have issued a hold recommendation for Ironwood Pharmaceuticals stock. The current number of analysts covering this company is 5. The highest target price is 13 USD, while the lowest target price is 0.7 USD. The median target valuation set by analysts is 1 USD. These forecasts and recommendations provide insight into how analysts view the future stock performance of Ironwood Pharmaceuticals.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for Ironwood Pharmaceuticals stock is: hold
Number of Analysts: 5
Highest Target Price: 13 USD
Lowest Target Price: 0.7 USD
Median Target Price: 1 USD

Fundamental Indicators

Indicator Data
Total Revenue: 351,409,984.00 USD
Net Income: 880,000.00 USD
Price-to-Book (P/B): /
PEG Ratio: /
Exchange: NasdaqGS
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Number of Employees: 253
Country: United States

Where to Buy Ironwood Pharmaceuticals Stock?

You can purchase Ironwood Pharmaceuticals stock on the NasdaqGS under the ticker symbol: IRWD. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Ironwood Pharmaceuticals Stock

Indicator Value
Company Revenue: 351,409,984.00 USD
EBITDA: 97,728,000.00 USD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share: 0.01 USD
Book Value Per Share: -1.88 USD
Total Cash: 88,559,000.00 USD
Total Cash per Share: 0.55 USD
Total Debt: 599,481,024.00 USD
Debt to Equity Ratio: -
Quick Ratio 4.39
Current Ratio 4.70
Free Cash Flow 80,306,000.00 USD
Operating Cash Flow 103,549,000.00 USD
Gross Margins 97.85 %
EBITDA Margins 27.81 %
Operating Margins 34.86 %
Profit Margins 0.25 %
Return on Assets 14.6 %
Return on Equity -
Earnings Growth (1 year) -
Revenue Growth (1 year) -23.0 %
Quarterly Earnings Year-over-Year Growth -
Market Capitalization 150,864,784.00 USD
Enterprise Value 661,776,960.00 USD
EV/Revenue 1.883
EV/EBITDA 6.772
Float Shares 123,641,823 shares
Shares Outstanding 161,820,000 shares
Held Percent Insiders 0.02 %
Held Percent Institutions 94.46 %
Shares Short 11,642,399
Shares Short Prior Month 16,247,025
Date Short Interest 2025-04-15
Short Percentage of Total Shares 7.19 %
Short Ratio 2.78
Beta 0.30
Short Percentage of Float 10.93 %
Implied Shares Outstanding 161,820,000

Frequently Asked Questions (FAQ)

According to our data, the company Ironwood Pharmaceuticals does not pay dividends yet, even in 2025.

Ironwood Pharmaceuticals shares are traded on the NasdaqGS stock exchange under the ticker: IRWD. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

According to our data, the recommendation for Ironwood Pharmaceuticals shares is from a total of 5 analysts. The average target price prediction is 1 USD per share.

The total number of Ironwood Pharmaceuticals shares on the exchange is 161,820,000.00 shares, which at the current market capitalization gives the company a total valuation of 150,864,784.00 USD.